Autoinflammatory & rare systemic diseases

IgG4-related uveitis. A French cohort and literature review

Semin Arthritis RheumPublished Retrospective multicentre cohort study and literature review

Authors' conclusion

Uveitis may be one of the initial symptoms of IgG4-RD, and IgG4-RD should be considered in the diagnostic workup of uveitis.

Study context

Population
Patients with uveitis and a concomitant definite diagnosis of igG4-related disease (IgG4-RD), from the French national IgG4-RD and systemic fibrosis database and from the literature
Participants
16 patients30 uveitis episodes
Outcome
Pattern of IgG4-related uveitis
Methodological detailsnationwide, PubMed literature review
  • Nationwide
  • PubMed literature review

Main finding

As reported in the abstract

Uveitis cases among total IgG4-RD patients in the national database
3 %
Uveitis inaugural in IgG4-RD (median 9 months before other symptoms)
4/16 (25 %)
Uveitis concurrent with other IgG4-related symptoms (median 15 months before diagnosis)
9/16 (56 %)
Uveitis appearing during follow-up (median 57 months after first symptoms)
3/16 (19 %)
Uveitis during follow-up associated with IgG4-RD in other organs
6/9 (67 %)
Bilateral
8/16 (50 %)
Granulomatous
5/10 (50 %)
Anterior
8/13 (62 %)
Intermediate
3/13 (23 %)
Panuveitis
4/13 (31 %)
Median serum IgG4 at diagnosis
3.2 g/L

Observational data: associations, not effects.

Further findings

At least one uveitis relapse during follow-up (median 6 years)

Patients with ≥1 relapse
8/16 (50 %)

Treatment and remission (29/30 flares with treatment data)

Steroids used
28/29 (97 %)
Remission with steroids
16/28 (57 %)
MTX (second/third line, with steroids) used
6/29 (21 %)
Remission with MTX
4/6 (67 %)
RTX (second/third line, with steroids) used
5/29 (17 %)
Remission with RTX
4/5 (80 %)
Uveitides requiring ≥2 lines of treatment for remission induction
One third

Original publication

IgG4-related uveitis. A French cohort and literature review. Semin Arthritis Rheum. Published 11 November 2023. doi:10.1016/j.semarthrit.2023.152278

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.